- Biocon Biologics has received U.S. FDA approval for Jobevne™, a biosimilar to Avastin® used in cancer treatment.
- Jobevne™ is indicated for various cancers, including metastatic colore…
Join the vibrant privacy-ensured Dzambhala community on
Want to give feedback on this story? Write to us at [email protected]